World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   54 records for 13 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
Not RecruitingNoISRCTN72928001
The contribution of health services in reducing chronic malnutrition in children infected by intestinal parasites in Bengo Province, Angola
07/04/2017
RecruitingNoISRCTN18101157
Efficacy of community educational interventions in nutrition and WASH/Malaria in reducing anemia in children under five, in the municipality of Dande - Angola
06/09/2016
RecruitingNoISRCTN16961836
Efficacy of a behavioural intervention based on food consumption, nutritional state and micronutrient deficiency in under five children, Angola
05/08/2016
AuthorisedYesEUCTR2015-002899-25-EE
Safety and Efficacy study of QVM149 in asthmatic patients
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-002899-25-GRSafety and Efficacy study of QVM149 in asthmatic patients08/02/2016
AuthorisedEUCTR2015-002899-25-LVSafety and Efficacy study of QVM149 in asthmatic patients11/01/2016
AuthorisedEUCTR2015-002899-25-ESSafety and Efficacy study of QVM149 in asthmatic patients07/01/2016
AuthorisedEUCTR2015-002899-25-PTSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-DESafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-BESafety and Efficacy study of QVM149 in asthmatic patients04/01/2016
AuthorisedEUCTR2015-002899-25-FISafety and Efficacy study of QVM149 in asthmatic patients23/12/2015
AuthorisedEUCTR2015-002899-25-ATSafety and Efficacy study of QVM149 in asthmatic patients15/12/2015
AuthorisedEUCTR2015-002899-25-BGSafety and Efficacy study of QVM149 in asthmatic patients13/04/2016
AuthorisedEUCTR2015-002899-25-DKSafety and Efficacy study of QVM149 in asthmatic patients08/01/2016
AuthorisedEUCTR2015-002899-25-SKSafety and Efficacy study of QVM149 in asthmatic patients07/12/2015
AuthorisedEUCTR2015-002899-25-IESafety and Efficacy study of QVM149 in asthmatic patients13/04/2016
AuthorisedEUCTR2015-002899-25-NLSafety and Efficacy study of QVM149 in asthmatic patients17/12/2015
AuthorisedEUCTR2015-002899-25-HRSafety and Efficacy study of QVM149 in asthmatic patients06/07/2016
AuthorisedEUCTR2015-002899-25-LTSafety and Efficacy study of QVM149 in asthmatic patients04/12/2015
AuthorisedEUCTR2015-002899-25-HUSafety and Efficacy study of QVM149 in asthmatic patients16/12/2015
28/11/2015
Not recruitingYesACTRN12615000107527
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola
05/02/2015
Not recruitingYesNCT01966731
Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
04/10/2013
 YesPER-032-12
A PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF GDC-0941 OR GDC-0980 WITH FULVESTRANT VERSUS FULVESTRANT IN ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS RESISTANT TO AROMA TASE INHIBITOR THERAPY
16/05/2012
Not recruitingYesNCT01540838
Slow Initial ß-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
23/02/2012
AuthorisedYesEUCTR2009-011360-10-ES
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2009-011360-10-FR 21/09/2009
AuthorisedEUCTR2009-011360-10-NOEffects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study. - SIGNIFY09/03/2010
AuthorisedEUCTR2009-011360-10-GBEffects of ivabradine in patients with stable coronary artery disease without heart failure.17/08/2009
Not RecruitingEUCTR2009-011360-10-DEEffects of ivabradine in patients with stable coronary artery disease without heart failure25/09/2009
Not RecruitingEUCTR2009-011360-10-EEEffects of ivabradine in patients with stable coronary artery disease without heart failure07/10/2009
Not RecruitingEUCTR2009-011360-10-FIEffect of ivabradine in patients with stable coronary artery disease without heart failure18/08/2009
Not RecruitingEUCTR2009-011360-10-HUEffects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study. - SIGNIFY04/09/2009
Not RecruitingEUCTR2009-011360-10-NLEffects of ivabradine in patients with stable coronary artery disease without heart failure18/08/2009
Not RecruitingEUCTR2009-011360-10-LTEffects of ivabradine in patients with stable coronary artery disease without heart failure24/09/2009
Not RecruitingEUCTR2009-011360-10-LVEffects of ivabradine in patients with stable coronary artery disease without heart failure19/08/2009
Not RecruitingEUCTR2009-011360-10-ATEffects of ivabradine in patients with stable coronary artery disease without heart failure.28/09/2009
Not RecruitingEUCTR2009-011360-10-GREffects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study. - SIGNIFY06/10/2009
Not RecruitingEUCTR2009-011360-10-ITEffects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study. - SIGNIFY01/10/2009
Not RecruitingEUCTR2009-011360-10-BEEffects of ivabradine in patients with stable coronary artery disease without heart failure.18/09/2009
Not RecruitingEUCTR2009-011360-10-CZEffect of ivabradine in patients with stable coronary artery disease without heart failure09/09/2009
Not RecruitingEUCTR2009-011360-10-IEEffects of ivabradine in patients with stable coronary artery disease without heart failure 15/09/2009
Not RecruitingEUCTR2009-011360-10-BGEffects of ivabradine in patients with stable coronary artery disease without heart failure.19/11/2009
Not RecruitingEUCTR2009-011360-10-SEEffects of ivabradine in patients with stable coronary artery disease without heart failure28/09/2009
Not RecruitingEUCTR2009-011360-10-DKEffects of ivabradine in patients with stable coronary artery disease without heart failure.25/11/2009
Not RecruitingEUCTR2009-011360-10-SIEffects of ivabradine in patients with stable coronary artery disease without heart failure19/10/2009
Not RecruitingEUCTR2009-011360-10-PTEffects of ivabradine in patients with stable coronary artery disease without clinical heart failure.07/08/2009
Not RecruitingISRCTN61576291Effects of ivabradine in patients with stable coronary artery disease without heart failure21/09/2009
Not RecruitingEUCTR2009-011360-10-SKEffects of ivabradine in patients with stable coronary artery disease without heart failure.11/09/2009
Not RecruitingCTRI/2010/091/000132A clinical trial with ivabradine in patients with stable coronary artery disease09-03-2010
Not recruitingNCT02446990Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure05/05/2015
07/08/2009
Not recruitingNoNCT00802594
A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
03/12/2008
     
1 2
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history